Biomea Fusion (BMEA) Cash & Equivalents (2020 - 2026)
Biomea Fusion (BMEA) posted Cash & Equivalents of $34.82 million for Q2 2026, down 38.1% from $56.22 million a year earlier and down 22.1% from the prior quarter.
Biomea Fusion (BMEA) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Biomea Fusion's Cash & Equivalents came in at $55.81 million, down 4.8% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -2.0% (FY2020 to FY2025).
- In prior years, Biomea Fusion's Cash & Equivalents was $58.65 million in FY2024 (-66.9%), $177.24 million in FY2023 (+57.9%), $112.25 million in FY2022 (-23.2%) and $146.09 million in FY2021 (+136.8%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q1 2021.
- On a year-over-year basis, Cash & Equivalents increased in 1 of the last eight quarters, with an average decline of 39.2%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 719.4%; the weakest was Q1 2025, with a decline of 75.3%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $44.69 million (Q1 2026), $55.81 million (Q4 2025) and $47.01 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.80 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 614.95 Bn | 533.47 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 505.05 Bn | 478.16 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 368.08 Bn | 322.46 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.32 Bn | 262.31 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 261.58 Bn | 235.26 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 236.05 Bn | 191.45 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 190.61 Bn | 164.80 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 169.86 Bn | 116.50 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Biomea Fusion | 53.54 Mn | -128.80 Mn | - | 34.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.82 Mn |
| Mar 31, 2026 | 44.69 Mn |
| Dec 31, 2025 | 55.81 Mn |
| Sep 30, 2025 | 47.01 Mn |
| Jun 30, 2025 | 56.22 Mn |
| Mar 31, 2025 | 35.86 Mn |
| Dec 31, 2024 | 58.65 Mn |
| Sep 30, 2024 | 88.32 Mn |
| Jun 30, 2024 | 113.66 Mn |
| Mar 31, 2024 | 145.29 Mn |
| Dec 31, 2023 | 177.24 Mn |
| Sep 30, 2023 | 199.46 Mn |
| Jun 30, 2023 | 223.26 Mn |
| Mar 31, 2023 | 86.65 Mn |
| Dec 31, 2022 | 112.25 Mn |
| Sep 30, 2022 | 132.66 Mn |
| Jun 30, 2022 | 148.83 Mn |
| Mar 31, 2022 | 156.57 Mn |
| Dec 31, 2021 | 146.09 Mn |
| Sep 30, 2021 | 157.19 Mn |
Biomea Fusion Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BMEA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BMEA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BMEA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();